Advertisement
CNSP vs PTGX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNSP is a StrongBuy and PTGX is a StrongBuy.
CNSP in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 19, 2026
CNSP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 39 cases where CNSP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNSP advanced for three days, in 176 of 207 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNSP as a result. In 81 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CNSP turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 40 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CNSP moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CNSP crossed bearishly below the 50-day moving average on September 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNSP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CNSP entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.375) is normal, around the industry mean (2.988). P/E Ratio (-0.303) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. CNSP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PTGX in +2.71% Uptrend, advancing for three consecutive days on October 21, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PTGX advanced for three days, in 233 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PTGX's RSI Oscillator exited the oversold zone, 13 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 57 cases where PTGX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
PTGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PTGX as a result. In 72 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The Moving Average Convergence Divergence Histogram (MACD) for PTGX turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 40 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
PTGX moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PTGX crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 42%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTGX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Aroon Indicator for PTGX entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. PTGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.617) is normal, around the industry mean (2.988). PTGX has a moderately high P/E Ratio (113.180) as compared to the industry average of (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (34.130) is also within normal values, averaging (438.009).
CNSP | PTGX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 26 | 34 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 47 Fair valued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 4 | |
SMR RATING 1..100 | 99 | 59 | |
PRICE GROWTH RATING 1..100 | 48 | 39 | |
P/E GROWTH RATING 1..100 | 100 | 27 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CNSP's Valuation (47) in the null industry is somewhat better than the same rating for PTGX (99) in the Biotechnology industry. This means that CNSP’s stock grew somewhat faster than PTGX’s over the last 12 months.
PTGX's Profit vs Risk Rating (4) in the Biotechnology industry is significantly better than the same rating for CNSP (100) in the null industry. This means that PTGX’s stock grew significantly faster than CNSP’s over the last 12 months.
PTGX's SMR Rating (59) in the Biotechnology industry is somewhat better than the same rating for CNSP (99) in the null industry. This means that PTGX’s stock grew somewhat faster than CNSP’s over the last 12 months.
PTGX's Price Growth Rating (39) in the Biotechnology industry is in the same range as CNSP (48) in the null industry. This means that PTGX’s stock grew similarly to CNSP’s over the last 12 months.
PTGX's P/E Growth Rating (27) in the Biotechnology industry is significantly better than the same rating for CNSP (100) in the null industry. This means that PTGX’s stock grew significantly faster than CNSP’s over the last 12 months.
| CNSP | PTGX | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 65% |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 77% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 78% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Advances ODDS (%) | 10 days ago 85% | 2 days ago 76% |
| Declines ODDS (%) | 2 days ago 90% | 9 days ago 75% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 73% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 73% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNSP’s FA Score shows that 0 FA rating(s) are green while PTGX’s FA Score has 2 green FA rating(s).
- CNSP’s FA Score: 0 green, 5 red.
- PTGX’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNSP’s TA Score shows that 3 TA indicator(s) are bullish while PTGX’s TA Score has 4 bullish TA indicator(s).
- CNSP’s TA Score: 3 bullish, 6 bearish.
- PTGX’s TA Score: 4 bullish, 6 bearish.
Price Growth
CNSP (@Biotechnology) experienced а -6.04% price change this week, while PTGX (@Biotechnology) price change was +1.32% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
Reported Earning Dates
CNSP is expected to report earnings on Nov 13, 2026.
PTGX is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
CNSP and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with PMN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then PMN could also see price increases.
| Ticker / NAME | Correlation To CNSP | 1D Price Change % | ||
|---|---|---|---|---|
| CNSP | 100% | -0.85% | ||
| PMN - CNSP | 51% Loosely correlated | +12.86% | ||
| RLYB - CNSP | 46% Loosely correlated | -0.98% | ||
| ORMP - CNSP | 38% Loosely correlated | -0.24% | ||
| AURA - CNSP | 34% Loosely correlated | -1.52% | ||
| PTGX - CNSP | 30% Poorly correlated | +0.07% | ||
More | ||||
PTGX and
Correlation & Price change
A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with MGTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then MGTX could also see price increases.
| Ticker / NAME | Correlation To PTGX | 1D Price Change % | ||
|---|---|---|---|---|
| PTGX | 100% | +0.07% | ||
| MGTX - PTGX | 47% Loosely correlated | -1.10% | ||
| PTCT - PTGX | 46% Loosely correlated | -0.48% | ||
| KURA - PTGX | 45% Loosely correlated | -1.00% | ||
| DNTH - PTGX | 45% Loosely correlated | -0.83% | ||
| ARQT - PTGX | 45% Loosely correlated | -2.89% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RTAI | 19.27 | 0.23 | +1.22% |
| Rareview Tax Advantaged Income ETF (RTAI) | |||
| TPYP | 42.51 | 0.28 | +0.66% |
| Tortoise North American Pipeline ETF (TPYP) | |||
| SLV | 52.26 | 0.14 | +0.27% |
| iShares Silver Trust (SLV) | |||
| EWK | 25.86 | -0.01 | -0.04% |
| iShares MSCI Belgium ETF (EWK) | |||
| NMS | 10.15 | -0.03 | -0.25% |
| Nuveen Minnesota Quality Municipal Income Fund | |||